Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

May 22 2001
Washington, D.C. (May 22, 2001) – Bernice Welles, M.D., will speak on behalf of the Biotechnology Industry Organization Wednesday at a Senate hearing to...
May 17 2001
WASHINGTON, D.C. (May 17, 2001) – Skyrocketing gasoline, home heating oil and natural gas prices underscore the importance of developing renewable energy...
May 16 2001
WASHINGTON, D.C. (May 16, 2001) -- It is likely that PresidentBush and Vice President Cheney will include bioenergy development in their new energy policy....
May 15 2001
WASHINGTON, D.C. (May 15, 2001) – Robert Chess, chairman of Inhale Therapeutic Systems, based in San Carlos, Calif., is scheduled to testify on behalf of the...
May 15 2001
WASHINGTON, D.C. (May 15, 2001) – Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today released the following statement in...
May 14 2001
WASHINGTON, D. C. (May 14, 2001) – More than 200 meetings with Capitol Hill legislators are scheduled for biotechnology industry representatives during the...
May 11 2001
WASHINGTON, D.C. (May 11, 2001) – The U.S. Senate passed a resolution (attached) declaring May 13 – 20 National Biotechnology Week, thereby recognizing...
May 10 2001
WASHINGTON, D.C. (May 10, 2001) – Biotechnology Industry Organization (BIO) President Carl B. Feldbaum today issued the following statement after congressional...
May 10 2001
WASHINGTON, D.C. (May 10, 2001) – Lila Feisee, director of government relations and intellectual property at the Biotechnology Industry Organization (BIO),...


Biotechnology News

September 1, 2014

MUNICH--(BUSINESS WIRE)--Diaverum, one of the world’s leading renal care providers today announced changes to its Executive Team and its underlying area structure. The...

September 1, 2014

OSLO, Norway--(BUSINESS WIRE)--Nordic Nanovector (the “Company”) announces that the subscription period for the previously announced subsequent repair offering (the “...

September 1, 2014

CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE Healthcare announced today that VIZAMYL™ (flutemetamol (18F) solution for injection) has received marketing authorisation...

September 1, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted...

August 31, 2014

BARCELONA--(BUSINESS WIRE)--Treating cardiac patients who have sleep apnoea with positive airway pressure (PAP) therapy shown to reduce mortality up to 38%